The Pharmacokinetics of Continuous Infusion Pralidoxime in Children with Organophosphate Poisoning
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 36 (6) , 549-555
- https://doi.org/10.3109/15563659809028048
Abstract
(1998). The Pharmacokinetics of Continuous Infusion Pralidoxime in Children with Organophosphate Poisoning. Journal of Toxicology: Clinical Toxicology: Vol. 36, No. 6, pp. 549-555. doi: 10.3109/15563659809028048Keywords
This publication has 20 references indexed in Scilit:
- What Target Pralidoxime Concentration?Journal of Toxicology: Clinical Toxicology, 1997
- Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphateArchives of Toxicology, 1993
- Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patientsArchives of Toxicology, 1992
- Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in childrenThe Journal of Pediatrics, 1990
- Clinical Pharmacokinetics in Infants and Children A ReappraisalClinical Pharmacokinetics, 1989
- Pralidoxime chloride continuous infusionsAnnals of Emergency Medicine, 1987
- Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in ratsToxicology and Applied Pharmacology, 1987
- Human Toxicity of Various OximesArchives of environmental health, 1967
- Organic Phosphorus Poisoning and Its TherapyArchives of environmental health, 1962
- Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular blockBiochemical Pharmacology, 1961